Abstract
In clinical practice, reduction of the symptom distress through the oncology nursing interventions can improve the quality of life in cancer patients. Oncology nurses may be able to apply our study finding to predict or monitor multiple distress symptoms in lung cancer patients undergoing chemotherapy.
Notes
This item was accepted for presentation at the 2019 International Nursing Research Congress in Calgary, Canada, but was not presented at the event.
Sigma Membership
Lambda Beta at-Large
Lead Author Affiliation
National Yang-Ming University, Taipei, Taiwan
Type
Poster
Format Type
Text-based Document
Study Design/Type
N/A
Research Approach
N/A
Keywords:
Chemotherapy, Lung Cancer, Symptom Distress
Recommended Citation
Chou, Hsiu-Ling, "Fatigue, sleep disturbances, and mood distress in patients with lung cancer during chemotherapy" (2019). INRC (Congress). 320.
https://www.sigmarepository.org/inrc/2019/posters_2019/320
Conference Name
30th International Nursing Research Congress
Conference Host
Sigma Theta Tau International
Conference Location
Calgary, Alberta, Canada
Conference Year
2019
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Acquisition
Proxy-submission
Fatigue, sleep disturbances, and mood distress in patients with lung cancer during chemotherapy
Calgary, Alberta, Canada
In clinical practice, reduction of the symptom distress through the oncology nursing interventions can improve the quality of life in cancer patients. Oncology nurses may be able to apply our study finding to predict or monitor multiple distress symptoms in lung cancer patients undergoing chemotherapy.